secwatch / observer
8-K filed June 10, 2026, 4:54 PM ET ticker BIIB CIK 0000875045
other material confidence high sentiment neutral materiality 0.05

Biogen shareholders elect all 10 director nominees and ratify auditor at 2026 annual meeting

BIOGEN INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-09 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-06-09
Exact text from the filing
Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Advisory vote on executive compensation at the 2026-06-09 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-06-09
Exact text from the filing
Stockholders approved the advisory vote on executive compensation
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Election of Directors at the 2026-06-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-06-09
Exact text from the filing
Stockholders elected ten nominees to the Board of Directors to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified
View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BIOGEN INC. filing history →

Source: SEC EDGAR
accession 0000950157-26-000700
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.